Introduction
In 1978, the ICRU published Report 29, Dose Specification for Reporting External Beam Therapy with Photons and Electrons (ICRU, 1978) . The present report deals with the problem of dose and volume specification for reporting intracavitary therapy. The principal subject is dose and volume specification for the intracavitary treatment of cervix carcinoma. However, the concepts developed in this report are designed to be applicable to other types of intracavitary applications, such as uterine body, etc.
Intracavitary therapy is often used in combination with external beam therapy and, therefore, the same terminology and definitions of terms are advocated. In particular, it would be desirable, whenever possible, to use the concepts of target volume, treatment volume and irradiated volume, as defined for external beam therapy. However, due to the high dose-gradient around the sources (throughout the tumor and target volume), the specification of the target absorbed dose in terms of the dose absorbed either at one or several reference point(s) within the target volume is not considered meaningful; therefore, the approach used in external beam therapy cannot be used.
The problem of dose specification is still more complicated when two or more target volumes are identified, some being treated either by external, or by intracavitary therapy and some by both methods. Furthermore, attention should be paid to the different time-dose patterns linked to each treatment method.
Based on clinical experience, different systems have been proposed for the treatment of cervix carcinoma. Three basic systems have been developed: the Stockholm system (Kottmeier, 1964)1, the Paris system (Lamarque and Coliez, 1951)1 and the Manchester 1 The references quoted are not the first references but those which seem to be the most comprehensive.
1 system (Paterson, 1948)1. Most of the systems used throughout the world are derived from these three basic systems.
As used here, the term "system" denotes a set of rules taking into account the source strengths, geometry and method of application in order to obtain suitable dose distributions over the volume(s) to be treated. For reporting, the system includes recommendations for specifying the application and possibly, as in the Manchester system, for calculating the dose rate (or dose) at specific points.
Typical applications according to the Stockholm system and the historical Paris system are presented in Figures 1.1 and 1.2, respectively. In both systems, applications have been reported in terms of "mg.h" (milligram hours), i.e., the product of the total mass or radium contained in the sources (in mg) and of the duration of the application (in hours).
The Manchester system (Paterson and Parker, 1934) , derived from the original Paris system, initiated about 1920, was designed to deliver a constant dose rate to defmed points near the cervix, irrespective of variation in size and shape of the uterus and vagina. In the Manchester system, an application was specified in terms of the "dose" in roentgens delivered at specific points such as points "A" and "B" (Figure 1.3) . Points A and B are still widely used throughout the world, although their exact meaning and their definition have not always been interpreted in the same way in different centers and even in a given center over a period of time.
In particular, some centers relate point A to anatomical references in the patient, others to the geometry of the sources.
The different methods of definition provide different values for the calculated dose rate to point A. As a result, where a prescribed dose to point A is used to calculate the total time for an insertion, different values of time Fig. 1 .1. The Stockholm system. Typical treatment of a cervix carcinoma with a radium application (uterus normal in size and shape). The intrauterine rod-shaped applicator is loaded with 53-88 mg radium (74 mg in the example shown). The vaginal applicator usually consists of a flat box containing 60-80 mg radium (70 mg in the example shown), but in special cases other forms of vaginal applicators may be used. Classically, the two applicators are not fixed to each other, but fixed or semi-fixed combinations have been developed. The vaginal applicator is held against the cervix and lateral fornices by careful and systematic gauze packing. Typically, 2 or 3 applications are given with 3-week intervals, each application lasting for 27-30 hours. Modifications of the Stockholm method, using larger amounts of radium, allow for application times of 10-18 hours at each treatment. The figure shows a typical application and the amount of radium in the two applicators as well as the dose-rate (Figure from Walstam, 1954). The active length of the sources is usually 16 mm, their linear activity being between 6 and 10 mg per cm, and their strength between 10 and 15 mg of radium. The total activity used is one of the lowest in use for such treatments and implies a typical duration of the application of 6-8 days. Typically, the ratio of the total activity of the vaginal sources to the total activity of the uterine sources should be 1 (with variations between 0.66 and 1.5). As far as the method of application is concerned, the historical Paris system does not imply any fixed distance between the vaginal sources, nor connection between vaginal and uterine sources (Pierquin, 1964) . In the classical Manchester system, point A is dermed as a point 2 em lateral to the central canal of the uterus and 2 em up from the mucous mem brane of the lateral fornix, in the axis of the uterus. Point B is defined as being in the transverse axis through points A, 5 cm from the midline. In clinical practice, dose calculations are often made from radiographs and point A is taken 2 em up from the flange of the intrauterine source and 2 em lateral from the central canal as indicated in the figure (Meredith, 1967) . In a typical application, the loading of intrauterine applicators varied between 20 and 35 mg of radium and between 15 and 25 mg of radium for each vaginal ovoid. The resultant treatment time to get 8000 R at point A was 140 hours. will be obtained, depending on the method used. It is therefore important to give a precise description of the method used to calculate the dose rate at specific points.
On the other hand, the Manchester system is based on a set of strict rules concerning the method of inserting the radium sources (in particular the choice of vaginal ovoids and their separation, and the relative strengths ofthe intrauterine and intravaginal sources). Assuming that the Manchester definition of point A is used, this will be the location where there is least variation in the dose rate from one source arrangement to another one.
It is opportune now to reconsider dose and volume specification for several reasons: 1. Introduction... 3 (i) radium is being progressively replaced by gammaray emitting substitutes (137CS, 192Ir and 60CO)2; (ii) new sets of sources are available, for which the old systems are not always suitable; (iii) SI units are now being widely used in the field of radiology; and (iv) computers are routinely used for calculations and complete sets of intracavitary dose distribution in several planes are now becoming available, from which new information and relationships can be derived.
